Medicare Enrolled
Dr. Stephen Richey, M.D., M.P.H
Internal Medicine · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Richey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Richey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Richey
Dr. Stephen Richey is an internal medicine specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Richey performed 31,738 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Richey received a total of $3,135 from 21 pharmaceutical and/or device companies across 34 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Richey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in TX
$3,135 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗31,738
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,600 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 6,200 | $43 | $137 |
| Paclitaxel chemotherapy injection | 5,700 | $0 | $8 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
5,695 | $0 | $13 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,299 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 760 | $0 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
632 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
592 | $10 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
583 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 540 | $1 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
283 | $66 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $91 | $368 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
224 | $12 | $108 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
210 | $2 | $13 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
190 | $2 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
187 | $102 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
104 | $23 | $157 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
94 | $1 | $7 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
93 | $9 | $56 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
92 | $6 | $431 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
88 | $16 | $100 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
81 | $57 | $211 |
| PSA test (prostate cancer screening) | 73 | $18 | $94 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
69 | $50 | $313 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
68 | $51 | $344 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
64 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
64 | $6 | $34 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
62 | $1 | $8 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
51 | $25 | $143 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 50 | $103 | $3,675 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
47 | $6 | $31 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $22 | $161 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $11 | $96 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 45 | $90 | $657 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
37 | $25 | $145 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $19 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
34 | $17 | $60 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
34 | $10 | $75 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
31 | $35 | $143 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
30 | $13 | $60 |
| Iron level test | 30 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
30 | $9 | $35 |
| New patient office visit, complex (60-74 min) | 29 | $161 | $709 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
26 | $1,163 | $4,802 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
25 | $1,163 | $4,929 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
25 | $8 | $49 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
25 | $133 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $139 | $496 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $93 | $357 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $62 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $119 | $565 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 17 | $20 | $128 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
16 | $5 | $23 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
15 | $5 | $26 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $135 | $694 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.7% high complexity
87.9% medium
10.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,135
Total received (2018-2024)
Avg $448/year across 7 years
Top 23% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
34
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$242
2023
$143
2022
$41
2021
$58
2020
$68
2019
$2,491
2018
$92
Payments by company (2024)
Elekta, Inc.
$111
Daiichi Sankyo Inc.
$45
SHIELD THERAPEUTICS INC
$31
Incyte Corporation
$23
Tempus AI, Inc
$18
PFIZER INC.
$14
Top 3 companies account for 77.1% of 2024 payments
All-time payments by company (2018-2024) ›
F. Hoffmann-La Roche AG
$2,130
Onkos Surgical, Inc.
$153
Janssen Biotech, Inc.
$114
Sirtex Medical Inc
$112
Elekta, Inc.
$111
AstraZeneca Pharmaceuticals LP
$68
Merck Sharp & Dohme Corporation
$52
Incyte Corporation
$45
Daiichi Sankyo Inc.
$45
Novartis Pharmaceuticals Corporation
$41
PFIZER INC.
$41
Genentech USA, Inc.
$37
SHIELD THERAPEUTICS INC
$31
Kite Pharma, Inc.
$29
Gilead Sciences, Inc.
$29
Eisai Inc.
$22
Tempus AI, Inc
$18
E.R. Squibb & Sons, L.L.C.
$18
Celgene Corporation
$15
Seagen Inc.
$13
GENZYME CORPORATION
$11
Top 3 companies account for 76.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · Abraxane · Alecensa · BOSULIF · CALQUENCE · DAURISMO · ERLEADA · Enhertu · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LYNPARZA · Lenvima · MEKINIST · MOSAIQ · Non-Covered Product · OPDIVO · PADCEV · SIR-Spheres Microspheres · TECENTRIQ · WELIREG · Yescarta · Zydelig
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
905
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Richey is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Richey experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Richey performed 6,600 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Richey receive payments from pharmaceutical companies?
Yes. Dr. Richey received a total of $3,135 from 21 companies across 34 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Richey's costs compare to other internal medicine physicians in Fort Worth?
Dr. Richey's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Richey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fort Worth
Browse internal medicine physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
By company
Onkos Surgical, Inc. Payments to Doctors
See all physicians who received payments from Onkos Surgical, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology